T-sCPY-s500R-H
T-sCPY-s500R-H is a NADPH-based FRET ratiometric biosensor probe. T-sCPY-s500R-H forms a 1:1 FRET pair upon binding to the eDHFR-HaloTag fusion protein through conjugation of the donor s500R (green fluorescence) and the acceptor sCPY (red fluorescence) with the HaloTag ligand and the eDHFR ligand (TMP), respectively; NADPH binding to eDHFR induces a conformational change that converts sCPY from a colorless spirolactam form to a red fluorescent form, enabling quantification of NADPH levels through the ratio of red/green fluorescence intensity (Ex = 488 or 490 nm; green channel Em = 500-580 nm; red channel Em = 600-700 nm). T-sCPY-s500R-H is applicable to research in fields such as cell metabolism studies, oxidative stress and NADPH homeostasis analysis, tumor metabolism, and NADPH-modulating drug screening.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 3100316-45-5
- 화학식: C86H98ClF6N13O15S2
- 분자량:1767.35
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
In Vitro
Operation Guide (The following is a recommended experimental protocol for guidance purposes only and requires adjustment according to your specific needs)
1. Stock Solution Preparation
1.1 Solvent: anhydrous DMSO.
1.2 Recommended concentration: 0.5-5 mM.
2. Working Solution Preparation
2.1 Diluent: cell culture medium containing 0.1% Pluronic F-127.
2.2 Working concentration: 50 nM; 500 nM.
2.3 Notes: adjust the working concentration as needed; prepare fresh before use.
3. Staining Procedure
3.1 Applicable to adherent cells:
3.1.1 Sample types: HEK293T, HeLa, U2OS cells, and U2OS cells expressing HaloTag-NLS.
3.1.2 Trypsin digestion is not specified as required.
3.2 Incubation conditions: incubate cells with T-sCPY-s500R-H at nanomolar concentrations (50 nM; 500 nM) for 12 h to overnight; protection from light is not specified as required.
3.3 Washing steps: direct labeling without washing is possible; or optionally wash twice with complete medium.
4. Control Setup
4.1 In vitro protein labeling experimental controls:
4.1.1 eDHFR-Halo protein alone (without probe, negative control).
4.1.2 T-sCPY-s500R-H probe alone (without protein, blank control).
4.2 Cell imaging controls:
4.2.1 Cells not transfected with eDHFR-Halo (negative control, to verify probe specificity)
5. Detection and Analysis
5.1 Instrument types: confocal microscope, microplate reader, fluorescence spectrophotometer.
5.2 Excitation/emission wavelengths:
5.2.1 Live-cell imaging: excitation Ex = 488 nm; donor (green) emission = 500-580 nm; acceptor (red) emission = 600-700 nm.
5.2.2 In vitro fluorescence detection: excitation Ex = 490 nm.
5.3 Result analysis:
5.3.1 Fluorescence intensity changes: binding of T-sCPY-s500R-H to HaloTag or eDHFR-Halo leads to enhanced green fluorescence; NADPH binding triggers a decrease in green fluorescence intensity (I535) and an increase in red fluorescence intensity (I635), thereby raising the FRET ratio (I635/I535); addition of NADPH further modulates fluorescence intensity.
5.3.2 Fluorescence localization: in unmodified adherent cells, fluorescence localizes to the cytoplasm; in U2OS cells expressing HaloTag-NLS, fluorescence localizes to the nucleus.
5.3.3 Color changes: donor Rhodamine produces green fluorescence; after NADPH stimulation, acceptor Rhodamine produces red fluorescence.
5.3.4 Protein labeling experiment: after the probe binds to eDHFR-Halo, SDS-PAGE fluorescence visualization detection shows a fluorescent band at ~50 kDa.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 3100316-45-5
-
분자량 1767.35
-
화학식 C86H98ClF6N13O15S2
-
SMILES
NC1=NC(N)=C(CC2=CC(OC)=C(OCCCCNC(C3=CC(C4(C(C=CC(N(C)C)=C5)=C5C(C)(C)C6=C4C=CC(N(C)C)=C6)N(S(=O)(CCNC(CCCS(=O)(N7C8(C(C=CC(NCC(F)(F)F)=C9)=C9OC%10=C8C=CC(NCC(F)(F)F)=C%10)C(C=C(C(NCCOCCOCCCCCCCl)=O)C=C%11)=C%11C7=O)=O)=O)=O)C%12=O)=C%12C=C3)=O)C(OC)=C2)C=N1
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocol
-
Research Protocol for Drug Screening technologies
Drug screening technologies are experimental and computational strategies used to identify small molecules or chemical probes that modulate a defined molecular target, signaling pathway, cellular phenotype, disease model, or patient-derived response profile. High-throughput screening tests many compounds in miniaturized assay formats, while quantitative high-throughput screening tests compounds across concentration ranges so that potency and efficacy can be inferred from concentration-response behavior rather than from a single-point signal. The core biological function of a drug-screening strategy is to connect compound exposure with measurable pathway activity, target modulation, cell-state change, viability, cytotoxicity, morphology, or disease-relevant phenotype. Assay performance must be evaluated before screening because hit identification depends on the separation between positive and negative controls, control variability, plate effects, outliers, and the statistical framework
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)